There have been few studies on the concordance between phenotypic assays for predicting human immu-nodeficiency virus type 1 (HIV-1) coreceptor usage. The sensitivity of ultradeep pyrosequencing combined with genotyping tools is similar to that of phenotypic assays for detecting minor CXCR4-using variants. We evaluated the agreement between two phenotypic assays, the Toulouse tropism test (TTT) and the Trofile assay, and ultradeep pyrosequencing for determining the tropism of HIV-1 quasispecies. The concordance between the TTT and Trofile assays was assessed for 181 samples successfully phenotyped by both assays. The TTT was 86 % concordant with the standard Trofile assay and 91.7 % with its enhanced-sensitivity version. The concor-dance be...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
International audienceThere have been few studies on the concordance between phenotypic assays for p...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This s...
Background: Ultra deep sequencing is of increasing use not only in research but also in diagnosti...
BACKGROUND Ultra deep sequencing is of increasing use not only in research but also in diagnostics....
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
International audienceThere have been few studies on the concordance between phenotypic assays for p...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
BACKGROUND: Determination of HIV-1 tropism is a pre-requisite to the use of CCR5 antagonists. This s...
Background: Ultra deep sequencing is of increasing use not only in research but also in diagnosti...
BACKGROUND Ultra deep sequencing is of increasing use not only in research but also in diagnostics....
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...